Delivery Order SPE2DB22D3301-SPE2DB25FX4HM

Award Date 10/24/24
Potential Completion Date 10/25/24
Potential Value $6.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,204.77 delivery order is for FERAHEME 510 MG/17 ML VIAL 17ML, a specialty medication. The contract has a firm fixed price and is set to expire on June 30, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,304.26 firm fixed-price delivery order is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,272.72 Firm Fixed Price Delivery Order covers the procurement of FERAHEME 510 MG/17 ML VIAL 17ML, a specialty pharmaceutical product. The contract has an ultimate completion date of July 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,285.63 Firm Fixed Price Delivery Order contract is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a specialty pharmaceutical product. The contract has an ultimate completion date of August 1, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,900.25 firm fixed price delivery order is for FERAHEME 510 MG/17 ML VIAL 17ML, a medical product, with a completion date of February 20, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $8,782.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of FERAHEME 510 MG/17 ML VIAL 17ML, a medical product, to support federal healthcare programs. The contract has an ultimate completion date of January 8, 2024. While the original solicitation was not provided, the award appears to be part of a...
This federal contract award, valued at $41,957.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that the DLA Troop Support Medical has in place with AmerisourceBergen, valued at up to $999,999,999 through December 2025. The purpose of this specific order is the supply of 4559407604 - FERAHEME 510 MG/17 ML VIAL 17ML, a...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of FERAHEME 510 MG/17 ML VIAL 17ML pharmaceutical products. The $8,843.22 award, which has a firm fixed price pricing type, was made by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of October 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FERAHEME 510 MG/17 ML VIAL 17ML. The contract has a ceiling value of $16,136.63 and runs through January 31, 2025. It is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,864.81 delivery order, which is part of a larger Indefinite Delivery Contract valued at $999,999,999, is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product. This contract supports military treatment facilities, veterans' healthcare programs, and other federal medical institutions with a...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX4HM
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,298.26, is for the delivery of 4566197516 - FERAHEME 510 MG/17 ML VIAL 17ML. The contract has an ultimate completion date of October 25, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 1/23/25, 9:10 AM